[Lipostabil in the treatment of viral hepatitis B in subjects who abuse alcohol].
A trial was conducted of clinical efficacy of lipostabil. Twenty-three lipostabil-treated patients with hepatis B abusing alcohol were compared to a control group receiving standard treatment. Lipostabil has advantages as it shortens jaundice, cholestasis, enhances recovery of lipid metabolism in erythrocytic membranes and antioxidant properties of blood. Lipostabil holds promise in multimodality treatment of combined hepatic lesions.
Tsyrkunov
V M
VM
D000437:Alcoholism / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D005217:Fat Emulsions, Intravenous / Q000627:therapeutic use*; D005235:Fatty Liver, Alcoholic / Q000097:blood / Q000188:drug therapy; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008563:Membrane Lipids / Q000097:blood; D010713:Phosphatidylcholines / Q000627:therapeutic use*
D005217:Fat Emulsions, Intravenous; D008563:Membrane Lipids; D010713:Phosphatidylcholines; C005152:lipostabil
Lipostabil v lechenii virusnogo gepatita B u lits, zloupotrebliaiushchikh alkogolem.